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Abstract
Fear memory formation is thought to require dopamine, brain-derived neurotrophic factor (BDNF) and zinc release in the
basolateral amygdala (BLA), as well as the induction of long term potentiation (LTP) in BLA principal neurons. However, no
study to date has shown any relationship between these processes in the BLA. Here, we have used in vitro whole-cell patch
clamp recording from BLA principal neurons to investigate how dopamine, BDNF, and zinc release may interact to modulate
the LTP induction in the BLA. LTP was induced by either theta burst stimulation (TBS) protocol or spaced 5 times high
frequency stimulation (5xHFS). Significantly, both TBS and 5xHFS induced LTP was fully blocked by the dopamine D1
receptor antagonist, SCH23390. LTP induction was also blocked by the BDNF scavenger, TrkB-FC, the zinc chelator, DETC, as
well as by an inhibitor of matrix metalloproteinases (MMPs), gallardin. Conversely, prior application of the dopamine
reuptake inhibitor, GBR12783, or the D1 receptor agonist, SKF39393, induced robust and stable LTP in response to a sub-
threshold HFS protocol (2xHFS), which does not normally induce LTP. Similarly, prior activation of TrkB receptors with either
a TrkB receptor agonist, or BDNF, also reduced the threshold for LTP-induction, an effect that was blocked by the MEK
inhibitor, but not by zinc chelation. Intriguingly, the TrkB receptor agonist-induced reduction of LTP threshold was fully
blocked by prior application of SCH23390, and the reduction of LTP threshold induced by GBR12783 was blocked by prior
application of TrkB-FC. Together, our results suggest a cellular mechanism whereby the threshold for LTP induction in BLA
principal neurons is critically dependent on the level of dopamine in the extracellular milieu and the synergistic activation of
postsynaptic D1 and TrkB receptors. Moreover, activation of TrkB receptors appears to be dependent on concurrent release
of zinc and activation of MMPs.
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Introduction
Evidence from behavioral and electrophysiological studies
indicates that the induction of long term potentiation (LTP) in
principal neurons of the basolateral amygdala (BLA) may underlie
the acquisition and consolidation of fear memories [1,2].
Significantly, fear memory formation is critically dependent on
the activation of dopaminergic afferents to the amygdala. Total
dopamine depletion prevents fear memory formation, an effect
that can be reversed by selective restoration of dopamine release in
the pathway from the ventral tegmentum to the BLA [3].
Moreover, the D1 family of dopamine receptors bi-directionally
modulates fear memory formation, with activation facilitating and
inhibition attenuating recall [4,5]. Consistent with this observa-
tion, activation of the amygdala in response to fearful faces is
dependent on D1 but not D2 receptor occupancy [6]. We have
shown that D1 receptors are found in close association with
NMDA receptors in the spines of BLA principal neurons [7],
where they function to modulate excitatory synaptic transmission
[8]. Hence, D1 receptors appear to be optimally positioned to
regulate the induction and expression of LTP in afferent inputs to
the BLA. Consistent with this hypothesis, the D1 receptor
antagonist, SCH23390, blocks low-frequency stimulation-induced
LTP in cortical inputs to the lateral amygdala [9], and D1 receptor
activation enhances both the duration and the magnitude of LTP
elsewhere in the brain [10].
Similarly, brain-derived neurotrophic factor (BDNF) has been
implicated in many forms of synaptic plasticity associated with fear
memory formation, including LTP [11,12]. High levels of BDNF
and its cognate receptor, tyrosine kinase receptor B (TrkB), are
found in the BLA [13,14], and recent studies have shown that
TrkB activation in the BLA is necessary for the acquisition and
consolidation of fear memories [14,15]. Consistent with these data,
a recent study has shown that the non-peptide TrkB receptor
agonist, 7, 8-dihydroxyflavone, enhanced both the acquisition of
fear and its extinction [16]. Moreover, point mutations of the two
main phosphorylation docking sites on the TrkB receptor have
been shown to modulate the both acquisition and consolidation of
fear learning and amygdala synaptic plasticity [17]. Together these
data suggest that BDNF and dopamine may play similar roles in
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neurons D1 receptor stimulation can trans-activate TrkB receptors
[18], and in the hippocampus dopamine-mediated persistence of
long-term memory (LTM) is reported to be mediated by BDNF
[19], further suggesting that a synergistic interaction between the
dopamine and BDNF systems could play a similar role in BLA-
dependent fear memory formation. While synaptic plasticity
underlying fear memory formation is assumed to occur in BLA
principal neurons, to date no studies have directly addressed the
role of D1 receptor activation on LTP in the BLA, or the role of
TrkB receptor activation on LTP, specifically in this cell
population. The present whole-cell patch clamp recording study
was designed to address these knowledge gaps and determine
whether these two systems act independently or synergistically to
regulate synaptic plasticity in principal neurons of the BLA.
Results
LTP induction in BLA principal neurons
Most in vitro studies that have examined the cellular mechanisms
underlying LTP formation in the BLA have used bath application
of GABAA receptor antagonists to block fast inhibitory synaptic
transmission and isolate evoked EPSPs. However, we have shown
that global reduction of GABAA receptor-mediated synaptic
transmission in the BLA can result in profound changes in
excitatory drive that would confound the interpretation of any
subsequent analysis of LTP [20]. To circumvent this potential
confound, we evoked monosynaptic EPSPs (eEPSPs) in BLA
principal neurons following stimulation of the external capsule
(EC, Figure 1A) by including picrotoxin (50 mM) in the patch
pipette to block GABAA receptor-mediated synaptic transmission
only in the principal neuron under study.
Multi-electrode recording studies in freely moving animals have
shown that coherent theta frequency oscillations occur between the
BLA and mPFC [21] and between the BLA and hippocampus [22]
duringfear memory acquisitionand recall. Hence, we reasoned that
theta frequency modulation of synaptic transmission onto BLA
principal neurons may play a significant role in fear memory
formation. Consequently, we first examined the effects of theta-
burst stimulation of the EC (TBS, see Methods) on the amplitude of
eEPSPs in BLA principal neurons. Here, TBS consisted of 40ms
bursts of high frequency stimulation(HFS) applied to the EC at 5Hz
for 5 seconds. As illustrated in Figure1B, TBS of the ECinduced a
LTP of the eEPSP that persisted for .45 minutes (blue diamonds).
When measured 30 min following TBS, the peak EPSP amplitude
was significantly greater than that of the baseline eEPSP amplitude
(144619%, n=6, 4 animals, P,0.001). Two-way ANOVA
revealed no significant effect of treatment at any time point for
either the access resistance or the membrane input resistance (F (10,
110)=0.57, P=0.98). We next examined the effects of spaced
5xHFS (5x100Hz/1s trains at 20s intervals) of the EC on LTP
induction in BLA principal neurons. In the hippocampus, TBS and
5xHFSinduceLTPbyactivating the samecAMP second messenger
cascade [23,24,25], but the response to 5xHFS was reported to be
more robust. Like TBS, 5xHFS of the EC induced a robust LTP of
the eEPSP in BLA principal neurons (15563% of baseline, n=5, 3
animals, P,0.001, Figure 1B, red squares). Two-way ANOVA
revealed no effect at any time pointoftreatment foreithertheaccess
resistance or the membrane input resistance (F (10, 110)=0.24,
P=0.99). Thus, both TBS and 5xHFS induced a significant LTP of
the eEPSP amplitude in BLA principal neurons.
We next determined whether an abbreviated HFS protocol
(26100Hz/1s trains at 20s intervals; 2xHFS) could induce LTP in
BLA principal neurons. In control ACSF, 2xHFS caused a brief
post-tetanic potentiation of the ePSP (PTP; 141611% of baseline)
that rapidly decayed back to baseline after 20 min (113612% of
baseline, n=8, 5 animals; Figure 1B, green triangles). Hence,
2xHFS was used in subsequent experiments as a sub-threshold
protocol to examine the effects of drug treatment on the sensitivity
of BLA principal neurons to LTP induction. Two-way ANOVA
revealed no significant effect of treatment at any time point for
either the access resistance or the membrane input resistance (F (9,
100)=0.26, P=0.9825). Moreover, because LTP induction by
TBS was more variable than the response to 5xHFS in most
subsequent experiments we used 5xHFS to study the mechanisms
underlying LTP induction in BLA principal neurons.
To examine any potential effects of treatment on presynaptic
release we also examined the paired-pulse ratio of eEPSCs (PPR,
see Methods), a measure of short-term presynaptic plasticity,
before, immediately after, as well as 10 min and 30 min after each
of the LTP induction protocols (TBS, 5xHFS and 2xHFS). Typical
examples of the paired-pulse response before and after each of the
stimulation protocols are illustrated in Figure 1C. Group data is
illustrated in Figure 1D. As expected all three stimulation
protocols elicited a significant reduction in PPR during the PTP
response immediately following the stimulation (P,0.05, n=6, 4
animals), whereas the PPR was not significantly different from
control values 10 or 30 min after the stimulation. These data
suggest that the LTP induced by either TBS or 5xHFS was most
likely postsynaptic and not presynaptic in origin.
Consistent with previous reports [26], inclusion of the calcium
chelator, BAPTA (10 mM) in the patch pipette, fully blocked the
induction of LTP by either TBS (10667% of baseline, n=6, 4
animals; Figure 2A) or 5xHFS (10466% of baseline, n=5, 3
animals; Figure 2B), further supporting a postsynaptic origin for
this response. Moreover, intracellular application of BAPTA
caused no enduring change in input resistance at any time point
measured (F (16, 136)=1275, P=1.27, Two-way ANOVA).
Finally, previous studies had reported that LTP induction in the
lateral amygdala was pathway specific [27,28]. Hence, in a parallel
study we examined the response of BLA principal neurons to
5xHFS of the thalamic input. In contrast to the response to 5xHFS
of the EC, stimulation of the thalamic input induced only a
transient increase in the eEPSP amplitude in BLA principal
neurons that was not significantly different from baseline when
measured 30 min after 5xHFS (11968% of baseline amplitude,
n=6, 4 animals, P,0.05; data not shown).
Dopamine-dependency of LTP induction in BLA principal
neurons
In vivo studies have shown that fear learning is dependent on
dopamine release in the BLA, and subsequent activation of
dopamine D1 receptors [3]. Consequently, we next examined the
role of D1 receptor activation on the induction of LTP in BLA.
Here, slices were pretreated with the D1 receptor antagonist,
SCH23390 (10 mM), for 10 min prior to, and during TBS. Bath
application of SCH23390 caused a significant attenuation of TBS-
induced LTP in BLA neurons (98612% of baseline, n=6, 4
animals, Figure 2C). These data not only suggested that TBS
induced the release of endogenous dopamine, but also that
subsequent activation of D1 receptors was necessary for the
induction of LTP in cortical pathways onto BLA principal
neurons. Similarly, prior application of SCH23390 also blocked
5xHFS-induced LTP in BLA principle neurons (11664% of
baseline, n=6, 5 animals, Figure 2D), Application of SCH23390
alone caused no enduring change in input resistance at any time
point measured (F (10, 88)=0.68, P=0.7366, Two-way ANOVA).
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share common receptor-effector signaling cascades.
To assess whether D1 receptor -mediated LTP in the BLA was
dependent on activation of the adenylate cyclase (AC) – cAMP -
protein kinase A (PKA) signaling cascade, we next tested the effect
of inclusion in the patch pipette of a membrane-impermeable AC
inhibitor, 29,5 9-dideoxy-39-ATP (0.5 mM), on 5xHFS-induced
LTP. Intracellular application of 29,5 9-dideoxy-39-ATP signifi-
cantly attenuated 5xHFS-induced LTP in BLA neurons (Control:
153611% of baseline, n=5; 29,5 9-dideoxy-39-ATP: 110610% of
baseline, n=6; P,0.001). Similarly, intracellular application of
the PKA inhibitor, KT5720 (100 nM), blocked not only the TBS-
induced LTP (112610% of baseline, n=5, 4 animals, Figure 2E),
but also the 5xHFS-induced LTP (10767% of baseline, n=5, 4
animals, Figure 2F). However, application of KT5720 caused no
enduring change in input resistance at any time point measured (F
(15, 98)=0.26, P=0.9761, Two-way ANOVA). Hence, the D1
receptor-dependent induction of LTP by either TBS or 5xHFS in
BLA principal neurons was also dependent on activation of the AC
– cAMP - PKA signaling cascade.
Having determined that LTP induction in BLA principal
neurons was dependent on local dopamine release and subsequent
activation of the D1 receptor - cAMP- PKA signaling cascade, we
next examined whether the induction of LTP could be modified
following bath application of the dopamine-specific monoamine
transport inhibitor, GBR12783 (10 mM). Blockade of dopamine
Figure 1. Stimulus dependent induction of LTP in BLA principal neurons. A) A schematic illustrating the position of the stimulation (Scortical
and Sthalamic) and recording (R) electrodes. EC, external capsule. B) Stimulation of the EC elicits long term synaptic plasticity in BLA afferents following
TBS (n=6, blue diamonds) and 56100 Hz (n=5, red squares), but not 26100 Hz (n=8, green triangles). C) Raw data show the effects of different
stimulation protocols on the PPR of EPSCs. EPSC amplitude was measured using paired stimuli pulses separated by 50 ms, before, immediately after,
and 10 min and 30 min post stimulation. D) A bar chart showing the group data for the effects of stimulation protocol on PPR. Note the large
decrease (P ,0.05) immediately post-stim, indicating the presynaptic component of post-tetanic-potentiation. * P,0.05. Error bars indicate S.E.M.
doi:10.1371/journal.pone.0026065.g001
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enhanced the magnitude of LTP in all neurons tested compared to
that induced in control ACSF (210610% of baseline, n=6, 4
animals, P,0.01, Figure 3A, red squares). Application of
GBR12783 caused no enduring change in input resistance at
any time point (F (10, 88)=0.68, P=0.7366, Two-way ANOVA).
However, because application of GBR12783 enhanced both PTP
(213610% of baseline, 10 min following 5xHFS) and LTP, we
next compared the PPR before, and at 10 and 30 min post of
5xHFS (Figure 3C, D). As illustrated in Figure 3D the PPR was
not significantly different from control values 10 or 30 min after
LTP induction (P ,0.05), suggesting that the facilitation of PTP
and LTP induced by GBR12783 was due to a facilitation of the
postsynaptic response and not due to recruitment of an additional
presynaptic component.
To ensure that blockade of dopamine re-uptake was not
recruiting additional receptor subtypes; we then tested whether the
enhancement of LTP was sensitive to D1 receptor antagonism.
Pretreating slices for 10 min with SCH23390 (10 mM) fully
blocked the GBR12783-enhanced LTP in all BLA principal
neurons tested (13464%, n=5, 3 animals, P,0.001, Figure 4,
hooped bar). Next, we tested whether exogenous application of the
D1 receptor agonist, SKF38393 (50 mM), could also facilitate
LTP. Pretreatment with SKF38393 for 10 minutes prior to 5xHFS
Figure 2. Calcium influx, activation of D1 receptors, and induction of the cAMP-PKA cascade are all required for the induction and
maintenance of LTP in BLA principal neurons. A, B) Inclusion of the calcium chelator, BAPTA (10 mM) in the patch pipette, fully blocked the
induction of LTP by either TBS (n=6) or 5xHFS (n=5). C, D) Endogenous dopamine was released during TBS and 5xHFS and was necessary for the
induction of LTP in BLA principal neurons. Incubation with SCH23390 (10 mM) before and during TBS (n=6) or 5xHFS (n=6) completely abolished the
induction of LTP. E, F) The induction LTP by either TBS or 5xHFS was dependent on activation of the cAMP-PKA signaling cascade. Intracellular
application of PKA inhibitor KT5720 (100 nM) fully blocked TBS-induced LTP (n=5), as well as 5xHFS-induced LTP (n=5).
doi:10.1371/journal.pone.0026065.g002
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(17564% of baseline, n=5, 3 animals, P,0.01, Figure 3B, red
squares; Figure 4, diagonal bar). Application of SKF38393 alone
caused no enduring changes in membrane input resistance (F (10,
110)=0.58, P=0.8302, Two-way ANOVA). Similarly, no change
was observed in the PPR at 10 or 30 min after LTP induction in
the presence of either GBR12783 or SKF38393 (Figure 3D). As
expected, prior application of SCH23390 fully blocked the
SKF38393-induced facilitation of LTP, and markedly attenuated
the induction of LTP compared to control (12264%, n=5, 3
animals, P,0.001 Figure 4, hatched bar). Together these data
suggested that release of endogenous dopamine and subsequent
activation of D1 receptors was necessary for 5xHFS induction of
LTP in BLA principal neurons, and that the magnitude of LTP
was tightly regulated by the activity of the local dopamine-
reuptake system.
Finally, addition of the AC inhibitor to the patch recording
solution significantly attenuated the ability of both SKF38393
(SKF38393:17969% of baseline, n=5; SKF38393 + 29,5 9-
dideoxy-39-ATP: 13667% of baseline, n=5; P,0.001) and
GBR12783 (GBR12783: 208613% of baseline, n=5;
GBR12783 + 29,5 9-dideoxy-39-ATP: 149610% of baseline,
n=5; P,0.001) to facilitate LTP. Similarly, intracellular applica-
tion of the PKA inhibitor, KT5720 (100 nM), blocked not only the
GBR12783 facilitated LTP (11665% of baseline, n=6, 4 animals,
Figure 5A, C), but also the SKF38393-induced facilitation of
LTP (11369% of baseline, n=5, 3 animals, Figure 5B, C).
Hence, D1 receptor activation appeared to facilitate LTP by
acting through activation of the classic AC – cAMP - PKA
signaling cascade and that this response was itself scaled by the
level of extracellular dopamine.
The role of BDNF in 5xHFS induction of LTP in BLA
principal neurons
Like the dopaminergic system, a growing body of evidence
suggests that fear learning is also dependent on local release of
BDNF and subsequent activation of its cognate receptor, the TrkB
receptor [14]. In the hippocampus, BDNF is released in response
Figure 3. Application of either the dopamine transport inhibitor, GBR12783, or the D1 receptor agonist, SKF38393 facilitated
5xHFS induced LTP in BLA principal neurons. A, B) Bath application of either the selective dopamine uptake inhibitor, GBR12783 (10 mM, n=6,
blue diamonds), or the selective D1 family receptor agonist, SKF38393 (50 mM, n=5, blue diamonds), before and during 5xHFS enhanced the
magnitude of LTP in principal neurons. The time of drug application is marked by the horizontal bar below the line plots. C) Raw data showing the
effects of drug application on the PPR of evoked EPSCs in BLA principal neurons. D) Bar chart showing the group data for the effects of drug
application on the PPR. ** P,0.01. Error bars indicate S.E.M.
doi:10.1371/journal.pone.0026065.g003
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field potential LTP in the BLA [15]. Hence, we next determined
whether local release of endogenous BDNF may also contribute to
5xHFS-induced LTP in BLA principal neurons. As TrkB receptors
are members of a family of receptor tyrosine kinases [30], we first
examined the effects of bath application of the tyrosine kinase
inhibitor, genistein (100 mM) on 5xHFS-induced LTP in BLA
principal neurons. As shown in Figure 6A, bath application of
genistein for 30 min prior to 5xHFS prevented the induction of
LTP (11866% of baseline, n=5, 4 animals, P,0.01; Figure 6A,
red squares, Figure 6C, grey bar), which is consistent with
previous studies in the hippocampus [31]. Application of genistein
caused no enduring change in input resistance at any time point
measured (F (14, 150)=0.31, P=0.9921, Two-way ANOVA).
However, the genistein effect could result from an action that was
independent of BDNF - TrkB receptor activation. Hence, we next
examined the effects on LTP induction of prior application of the
TrkB-immunoglobulin-G fusion protein, TrkB-Fc (1 mg/ml),
which scavenges BDNF and prevents TrkB receptor activation
[32]. As shown in Figure 6B, prior application of TrkB-Fc
prevented 5xHFS-induced LTP in BLA principal neurons
(11768% of baseline, n=6, 4 animals, P,0.01; Figure 6C,
black bar). Application of TrkB-Fc caused no enduring change in
input resistance at any time point (F (12, 104)=1.17, P=0.3169,
Two-way ANOVA).
Together these data suggest that 5xHFS of cortical inputs
resulted, not only in the release of endogenous dopamine, but also
endogenous BDNF release. TrkB receptors are coupled to three
main signaling pathways, including the mitogen-activated protein
(MAP) kinase kinase (MEK) cascade, phospho-inositide-3 kinase,
and phospholipase C (PLC). In aplysia, activation of the MEK
cascade is necessary for the induction of LTP and memory
formation [33]. To explore whether activation of the MEK
cascade downstream from BDNF was required for the induction of
LTP in the BLA, we included the MEK inhibitor, U0126 (10 mM),
in the patch recording pipette and allowed it to equilibrate for
30 min prior to LTP induction. Intracellular perfusion of U0126
prevented the induction of LTP in all neurons tested (11665% of
base line, n=5, 4 animals; P,0.01; Figure 6C, hooped bar).
Application of U0126 caused no enduring change in input
resistance at any time point (F (10, 110)=0.08, P=0.9999, Two-
way ANOVA).These results further suggested that BDNF release
and TrkB receptor activation were also critically involved in the
induction of LTP in BLA principal neurons, possibly acting via
activation of the MEK cascade.
However, BDNF is synthesized as a precursor protein,
preproBDNF, and proteolytic cleavage is required to generate
mature BDNF (mBDNF) [34]. ProBDNF is processed into
mBDNF by either matrix metalloproteinases (MMPs) [35] or by
tissue plasminogen activator (tPA)-dependent activation of plas-
Figure 4. The D1 receptor antagonist SCH23390 fully blocked
the induction of LTP by 5xHFS, as well as the facilitation of LTP
by GBR12783 and SKF38393. The bar chart summarizes the group
effects of different dopaminergic manipluations on the magnitude of
LTP induced by 5xHFS. Prior application of SCH23390 (10 mM) blocked
5xHFS induced LTP (grey bar) as well as GBR12783 (n=5, hooped bar)
or SKF38393 (n=5, stippled bar) facilitated LTP, ** P,0.01, * P,0.05.
Error bars indicate S.E.M.
doi:10.1371/journal.pone.0026065.g004
Figure 5. Facilitation of LTP by GBR12783 and SKF38393 are
dependent on activation of the cAMP - PKA signaling cascade.
A) Intracellular application of the PKA inhibitor, KT5720 (100 nM),
blocked the GBR12783 facilitated LTP (n=6) B) Application of KT5720
also fully blocked 5xHFS induced LTP in the presence of SKF38393
(n=5) C) Bar chart showing the group data for drug effects 30 minutes
post stimulation. *** P,0.001, Error bars indicate S.E.M.
doi:10.1371/journal.pone.0026065.g005
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completely absent in the BLA [37]. Hence, we reasoned that if
LTP induction in the BLA was dependent on TrkB receptor
activation, then the conversion of proBDNF to mBDNF by MMPs
could play a significant role in this process. Thus, blockade of
MPPs would be predicted to attenuate LTP. Consistent with this
prediction, application of the non-selective MMP inhibitor,
gallardin (10 mM), 30 min before 5xHFS significantly reduced
the magnitude of LTP to 13167% of baseline (n=4, 3 animals,
P,0.05; Figure 6C, diagonal bar), which is consistent with
previous studies in MMP-2 knockout mice [38]. Application of
gallardin caused no enduring change in input resistance at any
time point (F (12, 104)=0.6, P=0.8370, Two-way ANOVA).
Significantly, MMPs are only activated in the presence of
extracelluar zinc [39], and cortical afferents to the BLA are
known to contain vesicular zinc [40]. Hence, zinc released from
presynaptic terminals could directly activate MMPs in the BLA
following 5xHFS and trigger the conversion of proBDNF to
mBDNF. Consistent with this observation, inclusion of the copper-
zinc chelator (DETC, 20 mM) in the ACSF significantly attenuated
5xHFS-induced LTP in BLA principal neurons (12366% of base
line, n=5, 4 animals, P,0.01, Figure 6C, hatched bar). Whereas
application of DETC alone caused no enduring change in input
resistance at any time point measured (F (13, 112)=0.70,
P=0.6963, Two-way ANOVA). Moreover, as shown below,
DETC failed to block the facilitating effects of exogenous BNDF
application on 2xHFS induced LTP, suggesting that DETC
application was not affecting LTP-induction independently of
TrkB receptor activation. Together these data suggested that
5xHFS of cortical inputs into the BLA may cause a concomitant
release of dopamine, zinc, and BDNF resulting in the subsequent
activation of postsynaptic D1 and TrkB receptors, both of which
act to enhance the induction and maintenance of LTP.
Gain-control of LTP induction in BLA principal neurons
Elsewhere in the brain, D1 receptor activation or BDNF release
has been shown to lower the threshold for LTP induction [41,42].
Hence, we next determined whether activation of D1- or TrkB
receptors could affect the threshold for LTP induction in the BLA
using the 2xHFS stimulation protocol, which could not induce
LTP in principal neurons (see Figure 1B). Significantly, in the
presence of either the dopamine transport inhibitor, GBR12783 or
the D1 receptor agonist, SKF38393, 2xHFS induced a robust and
stable LTP in BLA principal neurons (GBR12783: 15368% of
baseline, n=5, 4 animals, P,0.01; Figure 7A, red squares, and
Figure 8C, grey bar; SKF38393:14866% of baseline, n=5, 4
animals, P,0.01; Figure 7B). Moreover, in all BLA principal
neurons tested pretreating slices for 10 min with the D1 receptor
antagonist SCH23390 (10 mM) fully blocked the GBR12783
(11164% of baseline, n=5, 3 animals, P,0.001, Figure 8C,
black bar) and SKF38393-mediated facilitation of LTP induced by
2xHFS (10765% of baseline, n=5, 3 animals, P,0.001, data not
shown). However, as illustrated in Figure 7C, analysis of the PPR
showed no significant difference from control values at 10 or
30min after 2xHFS LTP induction in the presence of either
GBR12783 or SKF38393 (Figure 7C, D) suggesting that
facilitation of LTP was not dependent on alterations in presynaptic
release mechanisms.
Consistent with this observation, inclusion of either BAPTA
(10 mM) (11968% of baseline, n=5, 3 animals, P,0.05,
Figure 8A, C, hooped bar) or the PKA inhibitor KT5720
(100 nM) (106610% of baseline, n=5, 3 animals, P,0.001,
Figure 8B, C, diagonal bar) in the patch pipette fully blocked the
induction of LTP by 2xHFS in the presence of GBR12783.
Together these data suggested that the postsynaptic mechanisms
underlying the induction of LTP by 2xHFS in the presence of
GBR12783 were similar to those mediating the response to
5xHTS. Significantly, application of the MEK inhibitor, U0126,
Figure 6. Activation of the BDNF and TrkB pathway is critical
for the induction of LTP in BLA principal neurons. A) Bath
application of of the non-selective receptor tyrosine kinase inhibitor,
genistein (100 mM), before 5xHFS (arrow) blocked the induction of LTP
in BLA principal neurons (n=5, red squares). B) Bath application of the
BDNF scavenger molecule, TrkB/Fc (1 mg/ml, n=6), for 30 min before
5xHFS prevented the induction of LTP in BLA. C) Bar chart summarizing
the group effects of modulating the BDNF and TrkB cascade on the
induction of LTP. Intracellular application of MEK inhibitor, U0126
(10 mM, n=5, hooped bar), for 30 min before recording abolished the
induction of LTP. Similarly, bath application of the MMP inhibitor,
GM6001 (Gallardin, 10 mM, n=4, diagonal hashed bar), or the copper-
zinc chelator (DETC, 20 mM, n=5, stippled bar) significantly attenuated
LTP in BLA principal neurons. ** P,0.01, * P,0.05. Error bars indicate
SEM.
doi:10.1371/journal.pone.0026065.g006
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GBR12783 (11465% of baseline, n=5, 3 animals, P,0.05,
Figure 8C, hatched bar), suggesting that activation of the BDNF-
TrkB pathway may also play a role in the induction of LTP by
2xHFS in the presence of GBR12783.
Consistent with this hypothesis, prior activation of TrkB
receptors with either the TrkB receptor agonist, (7, 8-dihydroxy-
flavone, 500 nM), or BDNF (100 ng/ml), reduced the threshold
for LTP-induction in response to 2xHFS (7, 8-dihydroxyflavone:
14968% of baseline, n=6, 5 animals, P,0.01, Figure 9A, red
squares, and Figure 9C, grey bar; BDNF: 142 69% of baseline,
n=4, 4 animals, P,0.01, Figure 9C, black bar). Application of
either the TrkB receptor agonist or BDNF alone caused no
enduring changes in input resistance at any time point measured
(7, 8-dihydroxyflavone: (F (10, 110)=1.44, P=0.1739; BDNF: (F
(13, 112)=0.17, P=0.9995 Two-way ANOVA)). Similar to the
GBR12783 response, intracellular application of BAPTA (10 mM)
(111611% of baseline, n=5, 3 animals, P,0.05, Figure 9C,
hooped bar) or KT5720 (100 nM) (11264% of baseline, n=5, 4
animals, P,0.01, Figure 9C, diagonal bar) fully blocked the
2xHFS induced LTP in the presence of the TrkB agonist. Hence,
facilitation of LTP induction in BLA principal neurons by D1 and
TrkB receptor activation appear to share a common pathway that
is dependent on postsynaptic calcium influx and activation of the
cAMP -PKA signaling cascade. Significantly, intracellular perfu-
sion of the MEK inhibitor U0126 (10 mM) also prevented the
facilitation of LTP by the TrkB receptor agonist, 7, 8-dihydroxy-
flavone, (116 66% of baseline, n=4, 3 animals, P,0.05,
Figure 9C hatched bar), suggesting that activation of D1 and
TrkB receptors may converge at the level of MEK to facilitate
LTP. In contrast, application of the zinc chelator, DETC, failed to
block the TrkB agonist effect (148 69% of baseline, n=6, 5
animalsP,0.01, Figure 9C striped bar), suggesting that exoge-
nous TrkB receptor activation can lower the threshold of LTP
induction in the BLA through direct activation of the MEK
cascade, and that this effect is independent of stimulus-induced
zinc release.
Figure 7. D1 receptor activation acts to reduce the threshold for LTP induction in BLA principal neurons. A) Application of the
dopamine reuptake inhibitor GBR12783 (10 mM, n=5), or B) the D1 receptor agonist SKF38393 (50 mM, n=5) induced a robust and stable LTP in BLA
principal neurons following 2xHFS. C) Raw data showing the effects of GBR12783 and SKF38393 on the PPR in BLA principal neurons. D) A bar chart
illustrating the group effects of drug application on the PPR of EPSCs before, immediately after, and at 10 min and 30 min post 2xHFS. ** P,0.01.
Error bars indicate S.E.M.
doi:10.1371/journal.pone.0026065.g007
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threshold for LTP induction in the BLA, and D1 receptor
antagonism completely abolished LTP in response to 5xHFS, we
next investigated whether these two transmitter systems may act
synergistically to facilitate LTP induction. Here, the D1 receptor
antagonist, SCH23390, was applied 10 min before 7, 8-dihydrox-
yflavone, which was applied 20 min prior to 2xHFS. Prior
application of SCH23390 fully blocked the ability of the TrkB
receptor agonist to lower the LTP threshold in response to 2xHFS
(109 68% of baseline, n=6, 5 animals, Figure 10A, C),
suggesting that a synergistic activation of D1 and TrkB receptors
was necessary to reduce LTP threshold. To examine if the reverse
relationship applied, we next examined the effects of prior
application of the BDNF scavenger, TrkB-Fc, on the facilitation
of LTP induced by 2xHFS in the presence of the dopamine
transport inhibitor, GBR12783. A 10 min pretreatment with
TrkB-Fc fully blocked the GBR12783-induced lowering of LTP
threshold (11469% of baseline, n=5, 4 animals, Figure 10B, C),
further supporting the hypothesis that a synergistic interaction
between these two transmitter systems was required to reduce LTP
threshold in BLA principal neurons.
Finally, we ran immunohistochemical- and single-cell RT-PCR
studies to confirm that all of the proteins predicted by our
physiological studies were expressed in the BLA. We have shown
previously that D1 receptors are found in the spines of BLA
principal neurons [7], where they form a close association with
NMDA receptors [8], and the Allen Brain Atlas shows moderate
to high mRNA expression levels for the matrix metalloproteinase
isoforms, MMP16 and MMP17, and also the TrkB receptor. Here,
we extend these observations using dual-immnuofluorescence
microscopy to show that protein for MMP16, MMP17, and the
TrkB receptor are extensively co-localized with CaMKIIa,a
major component of excitatory synapses in presumed BLA
principal neurons (Figure 11A–C).
To further confirm that neurons of the BLA express the
machinery necessary to mediate the synergistic modulation of LTP
induction by D1- and TrKB receptors, we extracted cytosolic
mRNA from physiologically identified BLA principal neurons and
performed single-cell RT–PCR to examine their mRNA expres-
sion profile. As expected, all cells sampled (n=15) expressed
mRNA transcripts for CaMKIIa. However, 7/15 neurons
sampled expressed only D1 receptor mRNA transcripts, 5/15
neurons expressed both D1 and D5 receptor mRNA transcripts,
and 3/15 neurons expressed only D5 receptor mRNA transcripts.
Intriguingly, all of the neurons that expressed D1 receptor mRNA
transcripts also expressed mRNA transcripts for the TrkB receptor
as well as ERK1/2. Moreover 8/15 neurons expressed MMP17
transcripts and 3/15 neurons expressed MMP16 mRNA tran-
scripts. Significantly, those neurons that expressed both D1 and D5
receptor mRNA transcripts expressed all of the proteins necessary
to facilitate a synergistic interaction between the D1 and BDNF
signaling cascades (Figure 11D).
Discussion
To the best of our knowledge, this study represents the first of its
kind to show that a) endogenous dopamine release and subsequent
D1 receptor activation is prerequisite for long-term potentiation of
glutamatergic input onto BLA principal neurons from cortical
afferents, b) that endogenous release of dopamine, zinc, and
BDNF results in a synergistic activation of D1 and TrkB receptors,
which together function to lower the threshold for LTP induction,
and that c) convergent activation of the MEK-ERK signaling
cascade may play a critical role in lowering the threshold for LTP
induction.
We believe that the results of our study offer a plausible
mechanism by which the results of several previously independent
studies can be unified into a common model of affective memory
formation in the BLA. For example, previous studies have shown
that the majority of dopaminergic terminals in the BLA make
synaptic contacts onto the spines of principal neurons [8], that
these spines co-localize D1- and NMDA receptors, which function
to modulate excitatory synaptic transmission [7], and that local
dopamine release and subsequent activation of D1 receptors is
necessary for the acquisition of fear memory [3]. Similarly,
Bolshakov, Shumyatsky and co-workers have shown that synap-
Figure 8. D1 receptor-dependent reduction of the threshold of
LTP induction requires calcium influx, and induction of the
cAMP-PKA and MEK-MAPK signaling cascades. A) Inclusion of
the calcium chelator, BAPTA (10 mM) in the patch pipette (n=5)
abolished the GBR12783 mediated LTP induction by 2xHFS. B) Inclusion
of the PKA inhibitor, KT5720 (100 nM) (n=5) also blocked the
GBR12783 mediated LTP induction by 2xHFS. C) Bar chart summarizing
the group effects of GBR12783 on LTP induction using 2xHFS. As
illustrated, pretreatment with SCH23390 (black bar), BAPTA (hooped
bar), KT5720 (diagonal bar), and U0126 (hatched bar) all fully blocked
the GBR12783-facilitated LTP (n=5 in each case). ** P,0.01. Error bars
indicate SEM.
doi:10.1371/journal.pone.0026065.g008
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but also fear memory formation [43,44]. Likewise, BDNF release
and the subsequent activation of TrkB receptors in the BLA has
been shown to play a critical role in regulating synaptic plasticity
and fear memory formation [43,45].
In the present study, we have shown that LTP can be induced
by either TBS or by spaced 5xHFS. Studies in the hippocampus
have shown that spaced HFS and TBS-induced LTP are cAMP-
PKA dependent [23,24,25]. Consistent with these data, we have
shown that in BLA principal neurons TBS- and 5xHFS-induced
LTP were both blocked by the D1 receptor antagonist SCH23390,
as well as by intracellular application of adenylate cyclase and
PKA inhibitors. Moreover, our paired pulse experiments showed
that the PPR was not altered after LTP induction, suggesting that
both TBS- and spaced 5xHFS-induced LTP may be dependent on
activation of the same postsynaptic cAMP-PKA signaling cascade
but independent of presynaptic modifications. In the hippocam-
pus, Kim and colleagues have shown that LTP induced by 4xHFS
at 40s intervals was not blocked by a PKA inhibitor [46]. The
reason(s) for the difference between their results and ours are not
immediately apparent but could be attributable to differences in
the recording method; whole-cell patch clamp recording com-
pared to field potential recording, or may simply reflect differences
in the sensitivity to LTP induction between the BLA and
hippocampus.
We have shown that D1 receptors co-distribute with the NMDA
receptor NR1 subunit in the spines of BLA principal neurons,
where they function to modulate NMDA currents [8]. The co-
activation of these two receptors has been shown to up-regulate
the surface expression and incorporation of the GluR1 receptor
subunit of the AMPA receptor at synaptic sites in hippocampus
[47]. Thus, concurrent activation of D1 and NMDA receptors
alone could functionally modulate the D1 receptor induction of
LTP in BLA principal neurons. Moreover, in this study we have
shown that inhibition of AC and PKA activity can block TBS- or
5xHFS-induced LTP as well as the facilitation of LTP induced by
the dopamine transport inhibitor, GBR12783 using 2xHFS,
suggesting that both the induction and facilitation of D1-induced
LTP in BLA principal neurons is dependent on activation of the
AC – cAMP -PKA signaling cascade. These results are consistent
with the seminal studies of Schafe and LeDoux showing that fear
memory consolidation in the amygdala is a cAMP- and PKA-
dependent process [48,49], Significantly, Jentsch and Taylor have
shown that stimulation of PKA activity in the amygdala facilitates
Figure 9. TrkB receptor activation lowers the threshold of LTP induction in the BLA. A) Application of the TrkB receptor agonist, 7, 8-
dihydroxyflavone (500 nM, n=6) facilitated the induction of LTP by 2xHFS. B) Left, raw data showing a typical PPR response before, and at 10 and
30 min after 2xHFS in the presence of the TrkB agonist. Right, a bar chart illustrating the group data. C) Bar chart summarizing the group effects of
TrkB receptor activation on LTP threshold using 2xHFS. Application of BDNF (100 ng/ml, n=4) for 30 min, mimicked the induction of LTP by 2xHFS
induced by 7, 8-dihydroxyflavone. Intracellular application of calcium chelator, BAPTA (10 mM, n=5, hooped bar) as well as the PKA inhibitor, KT5720
(100 nM, n=5, diagonal bar) or the selective MEK inhibitor, U0126 (10 mM, n=4, hatched bar) fully blocked the 7, 8-dihydroxyflavone facilitated LTP.
However, incubation with DETC (20 mM, n=6, striped Bar) did not block this effect. ** P,0.01, * P,0.05. Error bars indicate SEM.
doi:10.1371/journal.pone.0026065.g009
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appetitive learning may share common sub-cellular substrates in
the BLA.
Although our results suggest that D1 receptor activation alone
may be sufficient to enable the induction of LTP in principal
neurons, synaptic release of zinc together with activation of D1
and TrkB receptors might not occur independently of each other.
Hence, stimulation-induced BDNF activation of TrkB receptors
appears to be critically dependent on synaptically released zinc,
concurrent activation of D1- and TrkB receptors would then act
synergistically to markedly facilitate the induction of LTP in the
BLA. Indeed, in cortical networks cross-talk between the D1
system and the BDNF system may be the rule, rather than the
exception. Hence, Cammarota and colleagues have reported that
a similar interaction regulates long-term memory (LTM) forma-
tion in the hippocampus. Here, infusion of the D1 receptor
antagonist, SCH23390, blocked training-induced increase in
BDNF and prevented LTM. Conversely, infusion of the D1
receptor agonist, SKF38393, increased BDNF levels and facilitat-
ed LTM. Significantly, the D1 mediated effect was blocked by
infusion of a PKA inhibitor, and infusion of a BDNF function-
blocking antibody impaired the SKF38393-caused increase in
LTM [19], suggesting that hippocampal-dependent LTM requires
a synergistic interaction between these two systems and activation
of the AC-cAMP-PKA cascage. Our results could provide insight
into the cellular substrate mediating this cross-talk.
Moreover, we have shown that a key component potentially
linking synaptically released zinc and concurrent activation of D1-
and TrkB receptors is the functional expression of extracellular
matrix metalloproteinase (MMPs) by principal neurons of the
BLA. MMPs are not constitutively active under basal conditions,
and require synaptically released zinc to bind as a co-factor before
they become fully active [37,39]. Synaptic concentrations of zinc
can reach micromolar levels following HFS [50], suggesting that
extracellular MMPs in the BLA may be preferentially activated
only in response to strong (salient) sensory input. A similar activity-
dependent conversion of pro-BDNF to mBDNF has been reported
in cultured hippocampal neurons [51]. Here, low-frequency
stimulation was reported to release proBDNF [51]. In contrast,
following HFS substantial amounts of mBDNF were detected [29],
suggesting that a co-factor may be released during HFS that
facilitates the conversion of proBDNF to mBDNF.
Significantly, local release of zinc is restricted to a subset of
glutamatergic afferents arising from cortical/limbic structures, and
not from sub-cortical structures such as the thalamus, whose
terminals are devoid of synaptic zinc [50]. Recently, Humeau and
colleagues reported that simultaneous stimulation of cortical and
thalamic afferents onto neurons of the lateral amygdala (LA)
induced heterosynaptic LTP at cortical, but not at thalamic, inputs
[27]. Consistent with this observation, we were unable to induce
robust LTP in the thalamic pathway using stimulation parameters
that consistently induced LTP in the cortical input onto BLA
principal neurons. However, a presynaptic form of LTP in the
thalamic input onto LA neurons has been reported using a
prolonged period of paired-pulse stimulation [52]. Further studies
are required to determine if a similar mechanism exists in the
thalamic input onto principal neurons of the BLA. Nonetheless,
our data suggest that concurrent activation of cortical and
thalamic inputs into the BLA, as occurs during conditioned-
(CS) and unconditioned-stimulus (US) pairing in fear conditioning,
may selectively restrict BDNF-dependent LTP to the site of
cortical, sensory, input. Thus, presynaptic zinc release from the
cortical input may contribute to the maintenance of a precise
sensory topography for LTP induction (synaptic tagging) even
within the dendritic arbor of an individual principal neuron,
thereby preventing sensory generalization.
Synaptically released zinc has been shown to affect multiple
postsynaptic receptors and ion channels [50], and is able to
transactivate TrkB receptors in the hippocampal mossy fiber-CA3
pyramid synapse [53]. Hence, it is possible that the inhibition of
LTP observed following chelation of zinc by DETC may result
from processes that were independent of the inhibition of MMP
activation. However, the similarity of the response to DETC,
gallardin, and TrkB/Fc application, together with the inability of
DETC pretreatment to block the response to exogenous TrkB
receptor agonist application strongly suggests that DETC was
acting to directly block the activation of MMPs and, hence,
Figure 10. Synergistic activation of D1- and TrkB receptors
lowers the threshold for LTP induction in BLA principal
neurons. A) Preincubation with SCH23390 (10 mM) blocked the
induction of LTP by 2xHFS in the presence of 7, 8-dihydroxyflavone
(500 nM). B) Preincubation with TrkB/Fc blocked the induction of LTP
by 2xHFS in the presence of GBR12783. C) Bar chart illustrating the
synergistic interaction between D1 and TrkB receptors to reduce LTP
threshold in BLA principal neurons. ** P,0.01. Error bars indicate S.E.M.
doi:10.1371/journal.pone.0026065.g010
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activation of TrkB receptors. Consistent with this observation
MMPs have been shown to play a key role in facilitating synaptic
plasticity in the hippocampus and prefrontal cortex [54,55].
Importantly, our immunohistochemical and single cell RT-PCR
study revealed that principal neurons that express D1 and D5
receptor mRNA also show high protein expression for both
membrane-type matrix metalloproteinase 16 and 17 (MMP16,
MMP17), as well as the TrkB receptor. It is possible that either
MMP16 or MMP17 and the TrkB receptor may be co-localized in
the spines of principal neurons to facilitate BDNF-induced
modulation of sensory input. LTP could be induced in almost all
of the projection neurons that we recorded and, hence, MMP16
and MMP17 may serve the same function in different populations
of principal neurons. Moreover, principal neurons of the BLA may
be capable of differentially expressing multiple subtypes of MMPs,
each of which could facilitate LTP induction. Finally, principal
neurons of the BLA also have a random spatial orientation and an
extensive, overlapping, dendritic arbor. Following HFS, zinc
released from presynaptic cortical terminals may activate MMPs
in those neurons that express them, which could, in turn, modulate
the conversion of proBDNF to mBDNF even at synaptic contacts
where the postsynaptic neuron does not express MMPs. Thus zinc
release from limbic afferents may ensure input specificity for LTP
induction but may also allow generalization of the response to
clusters of neighboring principal neurons.
Figure 11. BLA projection neurons co-express mRNA and protein for D1- and TrkB receptors, as well as MMP17. A-A0)
Photomicrographs showing the high level of co-localization for TrkB (A, red) and CaMKIIa- (A9, green) immunoreactivity in putative principal neurons
of the BLA (A0, merged, double arrows). Note, a subpopulation of TrkB-positive neurons do not co-localize CaMKIIa (A0, open arrows, merged). B-B0)
Photomicrographs showing the high level of co-localization for MMP17 (B, red) and CaMKIIa- (B9, green) immunoreactivity in BLA neurons (B0,
merged, double arrows). Note, a subpopulation of MMP17-positive neurons do not co-localize CAMKIIa. C-C0) Photomicrographs showing the co-
localization of MMP16 (C, red) and CaMKIIa (C9, green) immunoreactivity in BLA neurons (C0, merged, double arrows). Note, a subpopulation of
CAMKIIa-positive neurons do not co-localize MMP16. All photomicrographs were taken from the basolateral nucleus of the BLA. In all images
magnification =63x, scale bar =10 mm. C) Photograph of an agarose gel showing the typical mRNA expression pattern for a D1- and D5- mRNA-
positive principal neuron. The associated table shows the relative expression of D1, D5, TrkB, MMP17 and ERK1/2 mRNA expression in single BLA
principle neurons.
doi:10.1371/journal.pone.0026065.g011
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threshold, in the synaptic response to sub-threshold stimulation
following application of BDNF or the dopamine transport
inhibitor, GBR12783, are also consistent with previous studies in
the prefrontal cortex and hippocampus. Here, endogenous DA
and BDNF have been shown to amplify LTP via activation of D1
receptors [10], and TrkB receptors [56] respectively. A similar
dopamine D1 receptor-dependent gain of sensitivity has also been
reported for spike-timing-dependent plasticity in CA1 hippocam-
pal neurons [57]. However, our study extends these observations
to demonstrate that, in the BLA, the gain of function effect in
response to DA or BDNF is dependent on the concurrent
activation of both receptor-effector cascades. Moreover, our results
further suggest that concurrent activation of D1 and TrkB
receptors may trigger second messenger cascades that converge
at the level of the MEK-ERK pathway.
We have shown that the D1 receptor-mediated facilitation of
LTP induction in BLA principal neurons is critically dependent on
theactivationoftheAC–cAMP- PKAsignalingcascade.Recently,
BDNF-dependent learning in the BLA was shown to be mediated
by activation of the MAPK and PI3K signaling pathways, and
abolished in the presence of MEK inhibitors [15]. Consistent with
this observation, we have shown that the MEK inhibitor, U0126,
abolished both 5xHFS-induced LTP as well as the gain of function
effect induced by either exogenous TrkB agonist or GBR12783
application. Significantly, Gean and colleagues have reported that
PI3K acts as a critical intermediary for PKA-induced MAPK
activation in the amygdala, and is required for amygdala LTP and
fear memory formation [58]. TrkB receptor activation can activate
PI3K and, hence, concurrent activation of D1 and TrkB receptors
may lower the threshold of LTP induction by convergent activation
of the MEK-MAPK signaling cascade. Although our study did not
examine PLCc activation, Musumeci and colleagues have recently
shown that mutation of the PLCc docking site of the TrkB receptor
also impairs acquisition of fear conditioning, suggesting that
synergism with the PLC cascade may also lower the threshold for
LTP induction [17].
In summary, our results show that following HFS synaptically
released zinc facilitates the synergistic interaction between
endogenously released dopamine and BDNF to control the
magnitude of LTP in BLA principal neurons. Aberrant activity
of the dopaminergic- and BDNF systems have been implicated in
the psychopathology of psychiatric disorders such as post-
traumatic stress disorder (PTSD) and depression [59], as well as
drug abuse [60]. Our observations on the synergistic interaction
between dopamine and BDNF and their ability to amplify sensory
input may provide important clues to the molecular mechanisms
underlying the development of sensory generalization in PTSD,
and sensitization in addiction.
Methods
Animals
Male Sprague–Dawley rats (5–7 weeks old, Charles River,
Raleigh, NC, USA) were used in this study. Every effort was used to
minimize both animal suffering and the number of animals
necessary to complete the study. All experimental protocols strictly
conform to National Institutes of Health guidelines for the Care and
Use of Laboratory Animals, and were approved by the Institutional
Animal Care and Use Committee of Emory University.
Slice preparation
Slices of 350 mm thickness containing the BLA were obtained as
described previously [61]. Briefly, the brains of isoflurane (Fisher
Scientific, Hanoverpark, IL, USA) anesthetized animals were
rapidly dissected and immersed in a cold (4uC) 95–5% oxygen/
carbon dioxide oxygenated ‘‘cutting solution’’ with the following
composition (in mM): NaCl (130), NaHCO3 (30), KCl (3.50),
KH2PO4 (1.10), MgCl2 (6.0), CaCl2 (1.0), glucose (10),
supplemented with kynurenic acid (2.0). Slices containing the
BLA were cut using a Leica VTS-1000 Vibratome (Leica
Microsystems Inc., Bannockburn, IL, USA). After cutting, slices
were maintained at 37uC in oxygenated ‘‘cutting solution’’ for at
least 50 min before transferring to regular artificial cerebrospinal
fluid (ACSF) containing (in mM): NaCl (130), NaHCO3 (30), KCl
(3.50), KH2PO4 (1.10), MgCl2 (1.30), CaCl2 (2.50), and glucose
(10). Slices were kept in the regular ACSF for at least 30 min
before recording.
Patch clamp recording
Individual slices were then transferred to a submersion-type
recording chamber mounted on the fixed stage of a Leica DMLFS
microscope (Leica Microsystems Inc., Bannockburn, IL, USA),
and continuously perfused by gravity-fed oxygenated 32uC ACSF
at a flow rate of 1–2 ml/min. Slices were viewed using differential
interference contrast (DIC) optics and infrared (IR) illumination
with an IR sensitive CCD camera (Orca ER, Hamamatsu, Tokyo
Japan). Thin-walled borosilicate glass patches electrodes (WPI,
Sarasota, FL, USA) which had a resistance of 4–6 MV were filled
with (in mM): 130K-gluconate, 2 KCl, 10 HEPES, 3 MgCl2, 2 K-
ATP, 0.2 NaGTP, and 5 phosphocreatine, adjusted to pH 7.3
with KOH, and having an osmolarity of 280–290 mOsm.
Individual BLA projection neurons were visualized in situ using
DIC microscopy in combination with a 40x water immersion
objective and displayed in real time on a computer monitor.
Projection neurons were identified according to their characteristic
size and shape [62], and were normally located between 50 and
120 mM beneath the surface of the slice. Data acquisition and
analysis were performed using a MultiClamp700B amplifier in
conjunction with pClamp10.0 software and a DigiData 1320A
AD/DA interface (Molecular Devices, Burlingame, CA, USA).
Whole cell patch clamp recordings were obtained and recorded
voltages were low-pass filtered at 5 kHz and digitized at 10–
20 kHz.
At the start of each experiment, a series of standardized current
clamp protocols were performed to further validate the identity of
BLA projection neurons [63]. Excitatory postsynaptic potentials
(EPSPs) onto BLA projection neurons were evoked as previously
described [64]. In brief, a concentric bipolar stimulation electrode
(FHC, Bowdoinham, ME, USA) was placed approximately
500 mm from the recorded neuron, close to the fiber tract of the
external capsule immediately adjacent to the BLA. In all
experiments, 50 mM picrotoxin was added to the patch solution
to block GABAA currents exclusively in the recorded neuron.
Slices were continuously perfused with oxygenated ACSF (32uC)
containing the GABAB receptor antagonist CGP36742 (5 mM).
This recording configuration allowed stable recording of isolated
EPSPs without contamination from epileptiform, recurrent EPSPs.
EPSPs (adjusted to 30% of maximal response) were evoked at
0.05 Hz, a 10 min baseline period was recorded in each
experiment, and recordings continued for at least 40min after
LTP induction. Initial EPSP amplitudes were normalized to the
average of the baseline EPSP amplitude. 5x high frequency
stimulation (HFS) LTP , an NMDA-receptor-dependent form of
LTP [65] consisted of five trains of stimulation at 100 Hz for 1-s
duration, applied with 20 s intervals; 2xHFS consisted of only two,
1-s trains of 100 Hz stimulation. Theta burst stimulation (TBS)
consisted of 40 ms duration, 100 Hz bursts delivered at 5 Hz for
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DC holding current was injected to maintain the membrane
potential at -70 mV, except during HFS or TBS when the
potential was adjusted to -60 mV to facilitate spike firing.
To calculate the paired-pulse ratio (PPR) two EPSCs were
evoked with an inter-stimulus-interval of 50 ms, PPR was
calculated as (eEPSC1/eEPSC2), where eEPSC1 and eEPSC2
represent the amplitude of the first and the second eEPSC,
respectively. PPR was measured before, immediately after, as well
as 10 min and 30 min after each of the LTP induction protocols
(TBS, 5xHFS and 2xHFS).
Drug application
The following drugs were obtained from (1) Sigma-Aldrich (St.
Louis, MO, USA): picrotoxin, 3-[[(3, 4-Dichlorophenyl) methyl]
amino] propyl]diethoxymethyl) phosphinic acid (CGP52432);
R-(+)-7-Chloro-8-hydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-ben-
zazepine (SCH23390 hydrochloride); 29,5 9-Dideoxy-39-ATP;
49,5,7-Trihydroxyisoflavone; 5,7-Dihydroxy-3-(4-hydroxyphenyl)-
4H-1-benzopyran-4-one (genistein); TrkB/Fc Chimera human;
(R)-N4-Hydroxy-N1-[(S)-2-(1H-indol-3-yl)-1-methylcarbamoyl-ethyl]-
2-isobutyl succinamide (gallardin); Diethyldithiocarbamic acid
(DETC); 7, 8-dihydroxyflavone hydrate; and BDNF. (2) Tocris
Bioscience (Ellisville, MO, USA):1-(2-Diphenylmethoxyethyl)-4-
(3-phenyl-2-propenyl)-piperazine dihydrochloride (GBR12783
dihydrochloride), (6)-1-Phenyl-2, 3, 4, 5-tetrahydro-(1H)-3-
benzazepine-7, 8-diol hydrobromide (SKF38393 hydrobromide);
(9R,10S,12S)-2,3,9,10,11,12-Hexahydro-10-hydroxy-9-methyl-1-
oxo-9,12-epoxy-1H-diindolo[1,2,3-fg:39,29,19-kl]pyrrolo[3,4-i][1,6]
benzodiazocine-10-carboxylic acid, hexyl ester (KT5720); and 1,4-
Diamino-2,3-dicyano-1,4-bis[2-a minophenylthio]butadiene (U0126).
All drugs were made as concentrated stock solutions in dH2O,
except picrotoxin, genistein, KT5720, U0126, gallardin and 7,
8-dihydroxyflavone, which were made as stocks in 100%
DMSO. The final concentration of DMSO was no more than
0.1% on final application. Drugs were applied in the ACSF using
a continuous gravity fed bath application unless specifically
stated.
Statistics
All data are expressed as the mean 6 SEM. The amplitudes of
the EPSPs were normalized to the average baseline EPSP
amplitude. All statistical tests were conducted using Excel 2007
or Graphpad Prism 4.0. Unless specified, the P value indicated for
comparisons of the amplitude of LTP are determined using
student’s t test on data obtained at 30-min post HFS. A two-way
ANOVA was performed to test any effect of treatment and time
on the access resistance or the membrane input resistance. A
P,0.05 was considered statistically significant for all cases.
Dual-immunofluorescence experiments
Immunofluorescence experiments were performed as previously
described [66]. Fluorescent immunohistochemistry was performed
using the following primary antibodies: rabbit monoclonal anti-
MMP17 (1:100, ab51075, Abcam, Cambridge, MA), rabbit
monoclonal anti-MMP16 (1:100, ab73877, Abcam, Cambridge,
MA), mouse monoclonal anti-CaMKIIa (1:1000, 05-532, Milli-
pore, Lake Placid, NY), and rabbit polyclonal anti-TrkB antibody
(1:1000, sc-12, Santa Cruz Biotechnology, Santa Cruz, CA). Co-
localization of MMP17 with CaMKIIa and TrkB with CaMKIIa
was determined by dual-immunofluorescent labeling. Representa-
tive BLA sections (from Bregma -2.30 mm to -3.14 mm) were
rinsed 3x (10 min each) in PBS, permeabilized with 0.5% Triton-
X 100 in PBS, and incubated for 48 hrs at 4uC with two
appropriate primary antibodies diluted in 0.5% Triton-X/PBS
solution. Sections were rinsed 3x (10 min each) in PBS and then
incubated at room temperature for 2 hrs with specific Alexa-Fluor
secondary antibodies (1:500, Molecular Probes, Invitrogen, and
Carlsbad, CA, USA), Alexa-Fluor 488 goat anti-mouse IgG and
Alexa-Fluor 568 goat anti-rabbit IgG. Following incubation with
secondary antibodies, sections were rinsed 3x (10 min each) in
PBS and 1x in 0.05 M phosphate buffer (PB), mounted on gelatin-
coated glass slides and coverslipped using Vectashield fluorescence
mounting medium (Vector Laboratories, Inc., Burlingame, CA).
Confocal spinning disk laser microscopy was used to analyze dual-
immunofluorescence and to obtain high-resolution photomicro-
graphs using an Orca R2 cooled CCD camera (Hammamatsu,
Bridgewater, NJ) mounted on a Leica DM5500B microscope
(Leica Mircosystems, Bannockburn, IL) equipped with a CSU10B
Spinning Disk (Yokagawa Electronic Corporation, Tokyo, Japan).
Antibody specificity
The antibody against MMP-17 was developed from a synthetic
peptide corresponding to residues on human MMP-17. MMP-17
antibody specificity was confirmed with Western blots by detection
of a single band of approximately 58 kDa. MMP-16 antibody was
developed against the synthetic peptide mapping at the C-terminal
of human MMP16. Specificity of the antibody was confirmed with
Western blots by detection of the single band at 57 kDa. The TrkB
antibody was raised against a peptide mapping within the C-
terminal cytoplasmic domain of Trk B of mouse origin. Specificity
of the antibody was confirmed by the manufacturer (Santa Cruz
Biotechnology) by detecting single band at 145 kDa, and has been
confirmed previously [67]. The CaMKIIa antibody was devel-
oped against a synthetic peptide corresponding to the N-terminus
of rat CaMKIIa and its specificity has been described previously
[68].
Single Cell RT-PCR
Following recording, cell cytoplasm was aspirated into the
recording pipette and expelled into a microcentrifuge tube. RT-
PCR reactions were performed for testing mRNA expression using
cDNA transcribed from individual cells. The RT product was then
amplified in two cycles, the first amplification step using V3 (dT)24
primer and cycling conditions of 95uC for 3 min, 50uC for 2 min
and 72uC for 3 min. For the second amplification step using V1
(dT)24 primer the cycling conditions were the same as mentioned
above with 20-cycle PCR amplification and a 6s extension per
cycle. The amplified cDNA from each cell was screened for the
expression of 18S rRNA as a positive control marker. The
amplified cDNA was subjected to another amplification step
using 2 ml of cDNA from each cell as a template and 100 nM
of each of the primers for D1,D 5, TrkB, MMP17, ERK1/2
and CamKIIa. PCR was performed using a 10 min hot start at
95uC followed by a 40 cycle program (94uC for 40 sec, 56uC for
40 sec and 72uC for 1 min).
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